ArticleAging2024
A differentially-methylated-region signature predicts the recurrence risk for patients with early stage lung adenocarcinoma.
Heng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it